NCT07000864 A Study of Live Tumor Fragments of Surgical Resections
| NCT ID | NCT07000864 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2028-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-07-01 with a primary completion date of 2028-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to obtain unused resected tumor tissue sample and associated clinical data from patients enrolled in this study to research ex vivo treatment response and integrity of tumor microenvironment using omics analysis and imaging while maintaining cell stability in a live environment.
Eligibility Criteria
Inclusion Criteria: * Ability to understand and sign informed consent * Planning to undergo a surgical procedure to remove cancer Exclusion Criteria: * Does not meet Inclusion criteria * No tissue for research available at time of surgery
Contact & Investigator
Debabrata Mukhopadhyay, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07000864 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07000864 currently recruiting?
Yes, NCT07000864 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT07000864 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT07000864 clinical trial?
NCT07000864 is sponsored by Mayo Clinic. The principal investigator is Debabrata Mukhopadhyay, PhD at Mayo Clinic. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.